Advances in the treatment of acute hepatic porphyria
Acute hepatic porphyria(AHP)is a rare disease with abnormal heme metabolism,and breakthroughs have been made in the treatment of this disease in recent years.In addition to conventional treatment methods,this article reviews new therapies for AHP that are in the stage of initial clinical application or are still in the research stage,including RNAi therapy,enzyme replacement therapy,genetic supplementation of DNA or mRNA,drug molecular chaperones,and glycine transporter inhibitors for reducing heme synthesis.Moreover,this article also reviews the treatment of AHP-related comorbidities and complications,such as hyponatremia and posterior reversible encephalopathy syndrome.High glucose infusion is the main treatment method for AHP in China,and the improvement in diagnosis and increased attention to rare diseases in China has promoted the development of the diagnosis and treatment of AHP,and it is expected to explore more suitable treatment methods for AHP in the Chinese population in the future.
国家科技期刊平台
NSTL
万方数据
